Prostatic Neoplasms: Clinical Trials

65 trials for Prostatic Neoplasms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

65 completed. 65 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 465Completed 65

Follow Prostatic Neoplasms: new trials by email Literature Review of Prostatic Neoplasms trials Research Report on Prostatic Neoplasms

Trials (filtered) newest first · largest first

All 65 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy
flotufolastat (18F), piflufolastat (18F) - Prostate Cancer
Phase 4CompletedBlue Earth Diagnostics622024-12-042026-07-13
PYLARIFY® PET/CT or PET/MRI in Men With Favorable Intermediate Risk (FIR) Prostate Cancer
Piflufolastat F 18 Intravenous Solution [PYLARIFY] - Prostate Cancer
Phase 4CompletedLantheus Medical Imaging2792024-02-082026-11-17
Self-Administered Nitrous Oxide (SANO) During Transrectal Prostate Biopsy to Reduce Patient Anxiety and Pain
Self-Administered Nitrous Oxide, Oxygen - Prostate Disease, Malignancy
Phase 4CompletedBeth Israel Deaconess Medical Center1432021-12-122024-01-30
A Study of Apalutamide in Chinese Participants With Non Metastatic Castration Resistant Prostate Cancer (NM-CRPC)
Apalutamide, Placebo, Androgen-deprivation Therapy (ADT) - Prostatic Neoplasms
Phase 4CompletedJanssen Research & Development, LLC752019-12-172026-07-30
Effect of a Reduced Dose Enzalutamide in Frail (m)CRPC Patients on Cognitive Side Effects
Enzalutamide - Prostatic Neoplasms, Castration-Resistant
Phase 4CompletedRadboud University Medical Center572019-05-302024-06-12
The Prognosis of Lipid Reprogramming With Rosuvastatin, in Castrated Egyptian Prostate Cancer Patients
Rosuvastatin 20mg, surgical castration - Prostate Cancer Metastatic
Phase 4CompletedNational Cancer Institute, Egypt702019-01-152021-03-02
Culture-guided Antimicrobial Prophylaxis in Men Undergoing Prostate Biopsy.
Ciprofloxacin, Trimethoprim/Sulfamethoxazole, Fosfomycin - Complication, Infection
Phase 4CompletedRadboud University Medical Center15382018-04-032022-05-10
Study to Evaluate the Safety and Efficacy of Switching From Zoladex® Monthly or Quarterly, to Eligard® Semiannual.
Leuprorelin Acetate (Eligard® 45 mg). - Prostate Cancer
Phase 4CompletedZodiac Produtos Farmaceuticos S.A.482017-11-142022-03-31
Volatile Anaesthesia and Perioperative Outcomes Related to Cancer Feasibility Study
Propofol, isoflurane, sevoflurane or desflurane - Cancer, Breast, Cancer Colorectal
Phase 4CompletedPeter MacCallum Cancer Centre, Australia1692017-08-272022-06-09
A Study of ELIGARD® in Hormone-dependent Prostate Cancer Patients
Leuprolide - Prostate Cancer
Phase 4CompletedAstellas Pharma Singapore Pte. Ltd.1072017-06-232024-11-26
Deep Versus Moderate Neuromuscular Blockade During Laparoscopic Surgery
Deep to Moderate NMB, Moderate to Deep NMB, Rocuronium - Cholecystitis, Endometriosis
Phase 4CompletedStony Brook University792016-12-272020-04-08
Study on Enzalutamide and Flutamide in Patients With Castration Resistant Prostate Cancer
Enzalutamide, Flutamide, Androgen deprivation therapy - Prostate Cancer
Phase 4CompletedAstellas Pharma Inc2062016-11-022024-12-09
4-weekly Versus 12-weekly Administration of Bone-targeted Agents in Patients With Bone Metastases
Pamidronate, Denosumab, Zoledronate - Breast Cancer, Prostate Cancer
Phase 4CompletedOttawa Hospital Research Institute2632016-08-012020-12-02
A Trial to Evaluate Safety of Firmagon® (Degarelix) in Indian Patients Diagnosed With Advanced Hormone-dependent Prostate Cancer
Degarelix - Prostate Cancer
Phase 4CompletedFerring Pharmaceuticals2302016-05-012021-12-15
Clinical Trial to Examine Individual Pain Tolerance in the Use of Two Anesthetic Techniques to Perform Saturation Prostate Biopsy
MIDAZOLAM, MEPIVACAÍNE, FENTANILE - Prostatic Cancer
Phase 4CompletedComplexo Hospitalario Universitario de A Coruña1002016-04-012018-01-26
Preoperative Brimonidine on IOP of Patients Undergoing RALP
brimonidine tartrate 0.2%, Carboxymethylcellulose Eye Drops - Prostate Cancer
Phase 4CompletedUniversity Health Network, Toronto262016-02-292018-09-27
Endothelial Function in Prostate Cancer Patients on Degarelix vs. Luteinizing Hormone-Releasing Hormone Agonists
Degarelix (LHRH antagonist), LHRH agonist, EndoPAT2000 - Prostatic Neoplasms, Cardiovascular Diseases
Phase 4CompletedRabin Medical Center802015-08-012019-06-12
Transperineal, MRI-guided, Prostate Biopsy
Transperineal, MRI-guided, prostate biopsy, Transrectal prostate biopsy (TRB): - Prostate Cancer
Phase 4CompletedUniversity Hospital, Strasbourg, France902015-05-012025-12-19
Combination of Cabazitaxel With Prednisolone With Primary Prophylaxis With PEG-G-CSF in Treatment of Patients With Prostate Cancer
CABAZITAXEL XRP6258, PEG-G-CSF, Prednisolone - Prostate Cancer
Phase 4CompletedSanofi212015-04-012017-01-24
The Effect of Propofol Based Total Intravenous Anesthesia on Oxidative Stress and Nitric Oxide
propofol, Desflurane - Prostate Cancer
Phase 4CompletedYonsei University502014-05-012015-07-29

Showing 20 of 65. Sign in to see all of them.

Narrower conditions

Breast Neoplasms (6)  ·  Neoplasms (5)  ·  Pain (4)  ·  Anxiety Disorders (2)  ·  Melanoma (2)  ·  Multiple Myeloma (2)  ·  Neoplasm Metastasis (2)  ·  Prostatic Hyperplasia (2)  ·  Acromegaly (1)  ·  Bone Diseases, Metabolic (1)  ·  Bone Neoplasms (1)  ·  Cardiovascular Diseases (1)  ·  Cholecystitis (1)  ·  Colonic Neoplasms (1)

Broader conditions

Genital Diseases (65)  ·  Genital Diseases, Male (65)  ·  Genital Neoplasms, Male (65)  ·  Male Urogenital Diseases (65)  ·  Neoplasms by Site (65)  ·  Urogenital Neoplasms (65)  ·  Prostatic Diseases (64)  ·  Urogenital Diseases (64)  ·  Neoplasms (60)  ·  Pathological Conditions, Signs and Symptoms (8)  ·  Skin Diseases (7)  ·  Skin and Connective Tissue Diseases (7)  ·  Breast Diseases (6)  ·  Digestive System Diseases (5)  ·  Neoplasms by Histologic Type (5)

Interventions

Zoledronic Acid (14)  ·  Dutasteride (4)  ·  Leuprolide (4)  ·  luprolide acetate gel depot (4)  ·  Triptorelin Pamoate (3)  ·  bicalutamide (3)  ·  enzalutamide (3)  ·  Androgen Antagonists (2)  ·  Ciprofloxacin (2)  ·  Desflurane (2)  ·  Prednisolone (2)  ·  Prednisone (2)  ·  Propofol (2)  ·  acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide (2)  ·  cabazitaxel (2)

Sponsors

Novartis Pharmaceuticals (9)  ·  Novartis (4)  ·  GlaxoSmithKline (3)  ·  Sanofi (3)  ·  Astellas Pharma Inc (2)  ·  Radboud University Medical Center (2)  ·  Yonsei University (2)  ·  American Medical Systems (1)  ·  Astellas Pharma Singapore Pte. Ltd. (1)  ·  AstraZeneca (1)  ·  Axogen Corporation (1)  ·  Bay State Clinical Trials, Inc. (1)  ·  Beth Israel Deaconess Medical Center (1)  ·  Blue Earth Diagnostics (1)  ·  Bucheon St. Mary's Hospital (1)

Countries

United States (21)  ·  Canada (8)  ·  Denmark (4)  ·  Netherlands (4)  ·  South Korea (4)  ·  Spain (4)  ·  Australia (3)  ·  Brazil (3)  ·  Finland (3)  ·  France (3)  ·  Germany (3)  ·  Greece (3)  ·  Italy (3)  ·  Japan (3)  ·  Belgium (2)

Top investigators

Anne Sophie P. Kancir, MD PhD (1)  ·  Brian Helfand, M.D. (1)  ·  Buys M Yvonne, MD FRCSC (1)  ·  Byung Ha Chung, Medicine (1)  ·  Carlos Hernandez, MD (1)  ·  Colin McCartney, MD (1)  ·  David Margel, MD, PhD (1)  ·  Evangelos Liatsikos, MD (1)  ·  Franklin M Chu, MD (1)

Results publications

PMID 17724727, PMID 19143027, PMID 24354113, PMID 25627076, PMID 25988518, PMID 27286961, PMID 30028657, PMID 30224019, PMID 30300367, PMID 31329922, PMID 34068083, PMID 34350976, PMID 35280654, PMID 36419331, PMID 36480560, PMID 37101774, PMID 38485614, PMID 40389061, PMID 41729277, PMID 4723349

NIH funding

R01CA138627 (1)